Status:

TERMINATED

Efficacy of the Spinal Cord Stimulation System as Salvage Therapy

Lead Sponsor:

Boston Scientific Corporation

Conditions:

Pain

Intractable Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The primary objective of this study is to evaluate the efficacy of spinal cord stimulation using the Precision implantable neurostimulation device for chronic and intractable pain of the trunk and or ...

Detailed Description

Chronic pain is managed by the sequential application of various strategies: medications, anesthetic injections, ablation, surgery, implantable intraspinal infusion pumps, and spinal cord stimulation....

Eligibility Criteria

Inclusion

  • Have chronic and intractable neuropathic pain of the trunk and/or limbs of moderate to severe intensity and have failed treatment with an intraspinal infusion pump or other SCS device. Determination of failure of treatment will be based on subject feedback. Subjects with an active intraspinal infusion pump but with inadequate pain control will be allowed to participate;
  • Be 18 years of age or older;
  • Be an appropriate candidate for the surgical procedures required for this study;
  • Be willing and able to comply with all study related procedures and visits;
  • Be capable of reading and understanding patient information materials and giving written informed consent.

Exclusion

  • Have failed immediate past treatment with an intraspinal infusion pump or other SCS device because of technical reasons associated with the device such as unresolved lead migration, battery depletion, etc.;
  • Have any evidence of neurologic instability requiring surgery;
  • Have any significant medical condition that in the opinion of the investigator may interfere with the conduct of the study or may adversely affect the subject's safety during the study;
  • Have any other active implantable device with the exception of a intraspinal infusion pump for pain medications;
  • Are pregnant or lactating or planning to become pregnant in the next year;
  • Have participated in any investigational drug or device trial in the last 4 weeks or plan to participate in any other investigational drug or device trial while on this study.

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2008

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT00387244

Start Date

August 1 2006

End Date

April 1 2008

Last Update

December 17 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Spectrum Care

Napa, California, United States, 94558